CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial-Reference-Cited by-同舟云学术

CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial

Published:2018-06-07 Issue:12 Volume:28 Page:5284-5292
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Froelich Matthias F.,Heinemann Volker,Sommer Wieland H.,Holch Julian W.,Schoeppe Franziska,Hesse Nina,Baumann Alena B.,Kunz Wolfgang G.,Reiser Maximilian F.,Ricke Jens,D’Anastasi Melvin,Stintzing Sebastian,Modest Dominik P.,Kazmierczak Philipp M.,Hofmann Felix O.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00330-018-5454-7/fulltext.html

Reference26 articles.

1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29

2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403

3. Köhne C-H, Cunningham D, Di Costanzo F et al (2002) Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 13:308–317

4. Giessen C, Graeven U, Laubender RP et al (2013) Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group. Ann Oncol 24:3051–3055

5. Modest DP, Ricard I, Heinemann V et al (2016) Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants : pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol 27:1746–1753

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Value of Quantitative Parameters of 18F-FDG PET/CT in Patients with Liposarcoma;Diagnostics;2024-09-12

2. Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis;PLOS ONE;2024-09-11

3. Textural heterogeneity of liver lesions in CT imaging - comparison of colorectal and pancreatic metastases;Abdominal Radiology;2024-08-08

4. Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial;Cancer Imaging;2024-06-17

5. Extracellular volume fraction can predict the treatment response and survival outcome of colorectal cancer liver metastases;European Journal of Radiology;2024-06